Agilent Technologies Inc (A)
137.97
-0.17
(-0.12%)
USD |
NYSE |
Nov 29, 16:00
Agilent Technologies Debt to Equity Ratio: 0.5748 for Oct. 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| October 31, 2024 | 0.5748 |
| July 31, 2024 | 0.4967 |
| April 30, 2024 | 0.4113 |
| January 31, 2024 | 0.4129 |
| October 31, 2023 | 0.4679 |
| July 31, 2023 | 0.5018 |
| April 30, 2023 | 0.4728 |
| January 31, 2023 | 0.5297 |
| October 31, 2022 | 0.522 |
| July 31, 2022 | 0.572 |
| April 30, 2022 | 0.5672 |
| January 31, 2022 | 0.5297 |
| October 31, 2021 | 0.5064 |
| July 31, 2021 | 0.5778 |
| April 30, 2021 | 0.6096 |
| January 31, 2021 | 0.5202 |
| October 31, 2020 | 0.4841 |
| July 31, 2020 | 0.4664 |
| April 30, 2020 | 0.5218 |
| January 31, 2020 | 0.5078 |
| October 31, 2019 | 0.507 |
| July 31, 2019 | 0.3788 |
| April 30, 2019 | 0.3508 |
| January 31, 2019 | 0.357 |
| October 31, 2018 | 0.3939 |
| Date | Value |
|---|---|
| July 31, 2018 | 0.3942 |
| April 30, 2018 | 0.4585 |
| January 31, 2018 | 0.4743 |
| October 31, 2017 | 0.4163 |
| July 31, 2017 | 0.4516 |
| April 30, 2017 | 0.4673 |
| January 31, 2017 | 0.4636 |
| October 31, 2016 | 0.4487 |
| July 31, 2016 | 0.4345 |
| April 30, 2016 | 0.4539 |
| January 31, 2016 | 0.4284 |
| October 31, 2015 | 0.3972 |
| July 31, 2015 | 0.4034 |
| April 30, 2015 | 0.3983 |
| January 31, 2015 | 0.3913 |
| October 31, 2014 | 0.3137 |
| July 31, 2014 | 0.3931 |
| April 30, 2014 | 0.4787 |
| January 31, 2014 | 0.495 |
| October 31, 2013 | 0.5106 |
| July 31, 2013 | 0.5642 |
| April 30, 2013 | 0.4441 |
| January 31, 2013 | 0.4415 |
| October 31, 2012 | 0.4558 |
| July 31, 2012 | 0.4546 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.4113
Minimum
Apr 2024
0.6096
Maximum
Apr 2021
0.5126
Average
0.514
Median
Debt to Equity Ratio Benchmarks
| Bio-Rad Laboratories Inc | 0.1604 |
| Bruker Corp | 1.271 |
| Azenta Inc | 0.00 |
| Harvard Bioscience Inc | 0.5796 |
| Bionano Genomics Inc | 0.306 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 11.85B |
| Total Liabilities (Quarterly) | 5.948B |
| Shareholders Equity (Quarterly) | 5.898B |
| Current Ratio | 2.089 |
| Net Debt Paydown Yield | -0.32% |